Cite
MLA Citation
Mathieu Le Gars et al.. “LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials.” Open forum infectious diseases, vol. 8, n.d., pp. S804–S805. http://access.bl.uk/ark:/81055/vdc_100150542774.0x000021